MTNB - Matinas BioPharma Holdings, Inc.
0.5282
-0.007 -1.287%
Share volume: 2,764
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 09-30-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q3 2024 | |
| Report Date | 05-10-2023 | 08-09-2023 | 11-08-2023 | 03-27-2024 | 11-13-2024 | |
| Cash flow financing | -4.000 K | -1.000 K | -1.000 K | -1.000 K | -67.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | -2.000 K | |
| Cash flow | -4.087 M | -2.193 M | -4.419 M | -4.579 M | 6.079 M | |
| Net income | -5.513 M | -6.060 M | -6.055 M | -5.314 M | -4.275 M | |
| Depreciation | 229.000 K | 234.000 K | 238.000 K | 240.000 K | 91.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 3.000 M | 6.198 M | 1.084 M | 2.960 M | 9.646 M | |
| Net Borrowings | -24.167 M | -20.096 M | -16.231 M | -11.937 M | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | -202.000 K | -16.000 K | 0.000 | 0.000 | |
| Cash Change | 24.857 M | 22.513 M | 18.216 M | 13.756 M | 6.079 M |